PALO ALTO, Calif., Oct. 19, 2017 -- Tesla will post its financial results for the third quarter of 2017 after market close on Wednesday, November 1st, 2017. At that time, Tesla will issue a brief advisory containing a link to the Q3 2017 Update Letter, which will be available on the Tesla IR website. Tesla management will hold a live question and answer webcast that day at 2:30pm Pacific Time (5:30pm Eastern Time) to discuss the Company’s financial and business results and outlook.
| What: | Date of Tesla Q3 2017 Financial Results and Q&A Webcast |
| When: | Wednesday, November 1st, 2017 |
| Time: | 2:30pm Pacific Time / 5:30pm Eastern Time |
| Shareholder Letter: | http://ir.tesla.com |
| Webcast: | http://ir.tesla.com (live and replay) |
Approximately two hours after the Q&A session, an archived version of the webcast will be available on the Company’s website.
For additional information, please visit ir.tesla.com.
Investor Relations Contact: Jeff Evanson Tesla [email protected] Press Contact: Dave Arnold Tesla [email protected]


Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 



